NanoRepro AG/€NN6
1D1W1MYTD1Y5YMAX
Capital at risk
About NanoRepro AG
NanoRepro AG is a German company operating in the healthcare industry, specializing in the development and distribution of diagnostic rapid tests. The company offers a range of products primarily focused on fertility, infectious diseases, and preventive care, providing over-the-counter solutions that cater to both professional and consumer markets. Founded in 2002, NanoRepro is headquartered in Marburg, Germany. The company leverages a network of distribution partners to enhance its market presence across various countries, reflecting a strategic focus on expanding its geographical footprint. NanoRepro's competitive strength lies in its emphasis on research and development, supporting its capability to introduce innovative diagnostic solutions.
- Ticker
- €NN6
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 22
- Headquarters
- Marburg, Germany
- Website
- www.nanorepro.com
NanoRepro AG Metrics
BasicAdvanced
€22M
-
-€0.16
0.46
-
Price and volume
Market cap
€22M
Beta
0.46
52-week high
€2.32
52-week low
€1.33
Average daily volume
9.8K
Financial strength
Current ratio
36.717
Quick ratio
33.077
Profitability
EBITDA (TTM)
-2.046
Gross margin (TTM)
62.10%
Net profit margin (TTM)
-45.83%
Operating margin (TTM)
-47.91%
Effective tax rate (TTM)
4.69%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
-3.42%
Return on equity (TTM)
-5.35%
Valuation
Price to revenue (TTM)
4.982
Price to book
0.61
Price to tangible book (TTM)
0.66
Growth
Revenue change (TTM)
-3.02%
Earnings per share change (TTM)
-2.87%
3-year revenue growth (CAGR)
-51.70%
10-year revenue growth (CAGR)
25.42%
3-year earnings per share growth (CAGR)
-18.27%
10-year earnings per share growth (CAGR)
-5.27%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.